Exelon Corp. (EXC) Tops Q3 EPS by 3c

Exelon Corp. (NASDAQ: EXC) reported Q3 EPS of $0.71, $0.03 better than the analyst estimate of $0.68.

GUIDANCE:

Exelon Corp. sees FY2024 EPS of $2.40-$2.50, versus the consensus of $2.45.

For earnings history and earnings-related data on Exelon Corp. (EXC) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
• Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink